Peter Honig

Insider Reports History

Location
La Jolla, CA
Signature
/s/ Nancy Smith, Attorney-in-Fact for Peter Honig
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Honig:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sesen Bio, Inc. Director Common Stock 40,000 $23,480 $0.5870 22 Jun 2022 Direct
Sesen Bio, Inc. Director Stock Option 65,000 22 Jun 2022 Direct
Karyopharm Therapeutics Inc. Director Nonstatutory Stock Option (right to buy) 34,000 24 May 2023 Direct

Insider Reports Filed by Peter Honig

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KPTI Karyopharm Therapeutics Inc. 24 May 2023 1 $0 4 Director 25 May 2023, 16:06
CARM Sesen Bio, Inc. 22 Jun 2022 2 $0 4 Director 24 Jun 2022, 18:31
KPTI Karyopharm Therapeutics Inc. 19 May 2022 1 $0 4 Director 20 May 2022, 16:06
KPTI Karyopharm Therapeutics Inc. 03 Dec 2021 1 $0 4 Director 07 Dec 2021, 09:37
KPTI Karyopharm Therapeutics Inc. 03 Dec 2021 0 $0 3 Director 07 Dec 2021, 09:35
CARM Sesen Bio, Inc. 20 Jul 2021 1 $0 4 Director 21 Jul 2021, 17:37
CARM Sesen Bio, Inc. 20 Jul 2021 0 $0 3 Director 21 Jul 2021, 17:33